Funding for this research was provided by:
Zhejiang Provincial Pharmaceutical Association Hospital Pharmacy Management Soft Science Research Funding Project of 2019 (2019ZYYG08)
Hangzhou Health Science and Technology Plan project in 2020 (A20200838)
Received: 20 June 2020
Accepted: 8 February 2021
First Online: 23 February 2021
Ethics approval and consent to participate
: According to the ministry of health "measures on ethical review of biomedical research involving human beings (trial 2007)"、WMA《Declaration of Helsinki》and the ethical principles of CIOMS《the international moral guide to human biological research》,Subject to review by the ethics committee, Agree to carry out this study according to the research scheme under review.I confirm that all methods were carried out in accordance with relevant guidelines and regulations. I confirm that all experimental protocols were approved by Ethics committee of hangzhou first people's hospital. I confirm that informed consent was obtained from all subjects.
: My manuscript is all about the two projects of breast cancer, I hope my article will help clinicians make decisions.I declare that there is no potential competitive interest in this article.I confirm that all authors have approved the manuscript for submission.I confirm that the content of the manuscript has not been published, or submitted for publication elsewhere.
: The authors declare no competing interests.